NautaDutilh assisted NewAmsterdam with their underwritten offering of ordinary shares and pre-funded warrants on Nasdaq. NewAmsterdam (Nasdaq: NAMS), a late-stage biopharmaceutical company focused on developing transformative...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here